Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

FDA clears generic version of SKB's Compazine

May 6, 1997

Clinical efficacy of Myotrophin in ALS and postpolio syndrome

May 6, 1997

ABT-431 evaluated in Parkinson's patients

May 6, 1997

Progress report on Cypros's adenosine and neuronal calcium channel preclinical programs

May 6, 1997

Neurotrophic factor gene therapy shows promise for motor neuron diseases

May 6, 1997

Daiichi and Fuji prepare new analgesics

May 6, 1997

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

May 6, 1997

Hyal's Oralease receives Emergency Drug Release status in Canada

May 5, 1997

Synthelabo develops alternative to AChE inhibitors for AD

May 5, 1997

Pierre Fabre prepares agents with antidopaminergic/antiserotonergic effects

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...